Cardinal Health, Inc. $CAH Shares Acquired by Russell Investments Group Ltd.

Russell Investments Group Ltd. boosted its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 18.7% during the third quarter, Holdings Channel.com reports. The fund owned 558,898 shares of the company’s stock after purchasing an additional 88,192 shares during the quarter. Russell Investments Group Ltd.’s holdings in Cardinal Health were worth $124,384,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Eurizon Capital SGR S.p.A. raised its holdings in shares of Cardinal Health by 10.8% in the 3rd quarter. Eurizon Capital SGR S.p.A. now owns 70,583 shares of the company’s stock worth $15,693,000 after purchasing an additional 6,870 shares during the period. CENTRAL TRUST Co lifted its stake in shares of Cardinal Health by 63.0% in the 3rd quarter. CENTRAL TRUST Co now owns 2,135 shares of the company’s stock valued at $475,000 after purchasing an additional 825 shares in the last quarter. Maryland State Retirement & Pension System grew its holdings in shares of Cardinal Health by 13.5% during the 3rd quarter. Maryland State Retirement & Pension System now owns 14,083 shares of the company’s stock worth $3,133,000 after purchasing an additional 1,670 shares during the period. Ritholtz Wealth Management grew its holdings in shares of Cardinal Health by 13.7% during the 3rd quarter. Ritholtz Wealth Management now owns 35,614 shares of the company’s stock worth $7,924,000 after purchasing an additional 4,287 shares during the period. Finally, UNIVEST FINANCIAL Corp grew its holdings in shares of Cardinal Health by 2.7% during the 3rd quarter. UNIVEST FINANCIAL Corp now owns 2,309 shares of the company’s stock worth $514,000 after purchasing an additional 60 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of NYSE CAH opened at $281.55 on Monday. Cardinal Health, Inc. has a 1-year low of $180.45 and a 1-year high of $286.29. The business has a 50-day moving average of $244.15 and a 200-day moving average of $225.24. The company has a market capitalization of $65.08 billion, a price-to-earnings ratio of 36.42, a PEG ratio of 2.15 and a beta of 0.53.

Cardinal Health (NYSE:CAH – Get Free Report) last posted its earnings results on Thursday, November 5th. The company reported $3.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.94 by $0.32. The business had revenue of $67.51 billion during the quarter, compared to analyst estimates of $66.67 billion. Cardinal Health had a negative return on equity of 102.72% and a net margin of 0.71%. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter last year, the firm earned $2.55 earnings per share. Research analysts expect that Cardinal Health, Inc. will post 12.97 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Monday, January 4th will be given a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Monday, January 4th. Cardinal Health’s dividend payout ratio is presently 26.65%.

Insider Buying and Selling

In other news, CEO Deborah Weitzman sold 7,354 shares of Cardinal Health stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total transaction of $1,731,499.30. Following the sale, the chief executive officer directly owned 77,901 shares of the company’s stock, valued at approximately $18,341,790.45. The trade was a 8.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Stephen M. Mason sold 35,000 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $236.40, for a total value of $8,274,000.00. Following the completion of the transaction, the chief executive officer owned 18,061 shares in the company, valued at approximately $4,269,620.40. This trade represents a 65.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 210,271 shares of company stock worth $49,626,657 over the last quarter. Company insiders own 0.12% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently commented on CAH shares. Mizuho set a $290.00 price target on shares of Cardinal Health in a report on Thursday, November 5th. JPMorgan Chase & Co. boosted their price objective on shares of Cardinal Health from $260.00 to $286.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 10th. Wells Fargo & Company boosted their price objective on shares of Cardinal Health from $245.00 to $277.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Leerink Partners set a $292.00 price objective on shares of Cardinal Health in a research report on Tuesday, August 11th. Finally, Morgan Stanley raised their target price on shares of Cardinal Health from $265.00 to $286.00 and gave the company an “overweight” rating in a research note on Friday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $279.44.

Get Our Latest Research Report on CAH

Cardinal Health Company Profile

(Free Report)

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.

Featured Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.